SWOT analysis of Business portfolio “General

Pharmaceutical Limited’’

Presented By Kamrun Nahar Papri

Introduction:
• The pharmaceutical industry in Bangladesh is one of the most developed technology sectors
within Bangladesh. Manufacturers produce insulin, hormones, and cancer drugs. This sector
provides 97% of the total medicinal requirement of the local market. The industry also exports
medicines to global markets, including Europe. Pharmaceutical companies are expanding their
business with the aim to expand the export market.
• The Pharmaceutical sector of Bangladesh has been transforming and evolving since the early 80s.
The sector has grown from strength to strength over the last 4 decades. Pharmaceutical industry is
one of the fast growing and ever changing market in the sector.
• The modern pharmaceutical industry is dated back to 19th century when first wholesale pharma
products were sold. Since then the industry is getting popularity day by day and is one of the most
important aspects of economy in the world.
 General Pharmaceutical Limited
History:
 General Pharmaceuticals Ltd. (GPL) is incorporated as Private Limited Company on the 5th day of April, 1984. Dr.
Momenul Haq, Managing Director, Dr. Gazi Nurun Nabi, was Director. They were friends and classmates since their
boyhood. M/S. General Pharmaceuticals Ltd. (GPL) stepped into manufacturing of drugs during 1987 with initial 7
products and minimum manpower. Now there are nearly 3000 employees in GPL inclusive of around 2000 Sales &
Marketing Force. The distribution network is spread all over Bangladesh with 600 distributions workers.
 General Pharmaceuticals Ltd (GPL) has stepped into 33th Years of its Excellence in 2020 with lots of inspiration from
previous successful years. We are immensely pleased to announce that GPL has started its production in 2011 at the state-
of-the-art factory (Unit 2) which is build in compliance with cGMP standards, where people are protected by assuring the
highest quality of the products and environment.
 The state-of-the-art factory is having the most modern ophthalmic & parenteral production facilities, dedicated steroidal
& non-steroidal facilities, high tech heating ventilation & air conditioning system (HVAC), SVP & LVP (including
Amino Acid) production facilities, effluent treatment plant & incineration process for waste management.
 Total site area is 29,792 Sqm & building foot print is 14,444 Sqm. The site master plan has been developed by APC,
Australia. The state-of-the-art factory is in compliance with UK MHRA, EU-GMP, TGA, ICH, PIC/S.
 Now GPL is able to export pharmaceutical products into the regulated countries like North America, South America,
European countries and Middle East, etc. and meeting the local demands.
 General Pharmaceutical Limited:
Location
• Headquarters; Shyamoli, Dhaka, Bangladesh .The company's manufacturing facility is located 45 miles from
Dhaka in Kaliyakair, Gazipur. Now the company has extended their manufacturing facility is located 48 miles
from Dhaka in Gazipur with the factory (Unit 2)
 General Pharmaceutical Limited

Mission
Their goal is to integrate quality management system into our all business
processes and decision-making practices so that we can ensure continual
improvement of products, services, procedures, processes and systems to
adapt changes for our customers through team work. They maintain our
business within our financial goals and objectives to establish our
competitive & leading position in the market. GPL is committed for timely
delivery of products and services, meeting our customer's requirements,
satisfying their needs and expectations as well as welfare of its community.
Vision:
Become the pharmaceuticals of choice through consistent product quality,
empowering people and satisfying stakeholders
 What is SWOT Analysis
 SWOT analysis is a business analysis process that ensures that objectives
for a project are clearly defined and that all factors related to the project
are properly identified. The SWOT analysis process involves four areas:
Strengths, Weaknesses, Opportunities and Threats. Both internal and
external components are considered when doing SWOT Analysis, as they
both have the potential to impact the success of a project or venture.
 The primary objective of a SWOT analysis is to help organizations
develop a full awareness of all the factors involved in making a business
decision.
 Perform a SWOT analysis before you commit to any sort of company
action, whether you are exploring new initiatives, revamping internal
policies, considering opportunities to pivot or altering a plan midway
through its execution.
 Use your SWOT analysis to discover recommendations and strategies,
with a focus on leveraging strengths and opportunities to
overcome weaknesses and threats.
Why do a SWOT Analysis?
• When we take the time to do a SWOT analysis, we’ll be armed with a solid strategy for
prioritizing the work that we need to do to grow our business.
• You may think that we already know everything that we need to do to succeed, but a SWOT
analysis will force we to look at your business in new ways and from new directions. we’ll look at
your strengths and weaknesses, and how we can leverage those to take advantage of the
opportunities and threats that exist in our market.
1. SWOT Analysis brings to light whether the business is healthy or sick.
SWOT Analysis Of General Pharma
Strength:
• 1. Experience executives
• 2. Large customer base
• 3. Strong regulatory team
• 4. Presence in the market
• 5. Lower employee mobility
• 6. Decentralized decision-making structure
• 7. Strong Brand image and favorable corporate image.
Weakness:
1.low profitability
2. low profit growth
3. time consuming decision making
Fragile share market images to customers
Lack of proper integration between functional units.
SWOT Analysis
Opportunity:
• 1. invention of new product
• 2. global market
• 3. in growth stage of the company cycle
• Government regulations are in favor of local manufactures.
• Domestic API Production
Threat:
• 1. Growing competitors of pharmaceutical company
• 2. Inadequate power supply
• 3. Price hike of raw material
• Highly regulated market
• Political inability
Marketing and sales strategies:
From the day of launch the company has come forward a long way. Even if there are some lacking in
the Marketing department. The company has lacking's but they have fulfilled the vision of providing
quality products to mankind by proper cGMP guidelines.
1.They maintain good relationships with physicians which is a key aspect of being a successful
pharmaceutical marketer.
2. They connect with customers emotionally
3. They create visual aids for physicians
4. They participate in conferences and events
5. They examine how well pharmaceutical marketing techniques are working.
6. They have fulfilled the vision of providing quality products to the customers by proper GMP
guidelines
Employees and Job openings:
The organization ensure that-
 Right number of people
 Right kind of people
 At the Right place
 At the Right time
Now there are nearly 3000 employees in GPL inclusive of around 2000 sales & Marketing Force.
The distribution network is spread all over Bangladesh with 600 distributions workers.
Growth:
 General Pharmaceuticals Ltd. (GPL) is one of the fastest growing
pharmaceutical finished formulation manufacturing companies in
Bangladesh with a mission to provide innovative high quality range of
healthcare products.
GPL has been striving for more than 27 years and has devoted entirely to
the development of excellent pharmaceutical finished products.
 GPL has crossed numerous milestones in its journey. Turnover has
grown multifold.
We have introduced several new life saving molecules for the first time
in Bangladesh and have possessed an excellent production infrastructure.
It has created effective systems and built committed teams of
professionals, which ensure that GPL is fully prepared and ready to
successfully take on the challenges of the future.
 General Pharmaceuticals has about 248 dosage forms for marketing
within Bangladesh.
Production:
• In order to meet the growing challenges of medical science, stringent
regulatory requirement of both local and international market and post
TRIPS agreement GPL has established its second state-of-the-art
manufacturing facility at Shafipur, Kaliakair, Gazipur.
• This plant has been designed by APC, leading consultant of the world
keeping focus on the contemporary and upcoming changing therapeutic
needs of mankind.
• This manufacturing facility has been designed with an aim to comply with
the international norms of cGMP and with particular emphasis on meeting
standards of the UK MHRA, TGA, WHO, ICH, ISO, PIC/S and other
strict regulatory body.
• By introducing sterile products in addition to others, GPL endeavors to
meet the diverse needs of patient and health professionals
• Production Facilities:
• The company's manufacturing facility is located 45 miles from Dhaka in Gazipur, where they
• produce various dosage form like Film Coated Tablet, Enteric Coated Tablet, Dispersible Tablet,
• Immediate Release Tablet, Modified Release Tablet, Sustain Release Tablet, Chewable Tablet,
• Immediate Release Capsule, Modified Release Capsule, Enteric Coated Capsule, Liquid in Hard
• gelatin Capsule, Lotion, ORS, Syrup, Suspension, Oral Gel, Antiseptic Mouthwash,
• Antiseptic Solution, Powder for Suspension, Cream, Ointment (Water base & Oil base).
• Now the company has extended their manufacturing facility is located 48 miles
• from Dhaka in Gazipur with the factory (Unit 2), where they
• produce Ophthalmic & Injectable drugs such as Solution, Suspension &
• Ointment, Nasal Preparation, Large Volume Parenteral (LVP), Small Volume Parenteral (SVP),
• Dry Vial, Pre-filled Syringe Injection in key therapeutic segments. This is one and only
• dedicated steroid & Non-steroid pharmaceuticals facilities in Bangladesh.
• Total site is 29,792 square metres and building foot print is 14,444 square metres
 Global Footprint

Exporting Countries:
Asia: Afghanistan, Bhutan, Cambodia, Sri Lanka, Myanmar,
Hong Kong, Macau, Vietnam, Maldives, Philippines, Yemen.

Africa: Tchad, Kenya, Somalia, Burkina Faso, Namibia,

Botswana, Zimbabwe, Tanzania, Ethiopia, Cameroon.

Central & South America: Jamaica, Belize, Dominican

Republic
Market Analysis:
• - Domestic market
• - International market
• The company sells its products in Bangladesh and exporting to both developed and developing
• countries around the world. They has entered into exports fields by registering its products in the
• following countries: around the world. They had entered into export fields by registering its
• products in the following countries:
• Asia: Afghanistan, Bhutan, Cambodia, Sri Lanka, Myanmar, Hong Kong, Macau, Vietnam,
• Maldives, Philippines Africa: Kenya, Somalia, Mauritius, Nigeria, Libya Central & South
• America: Belize, Guatemala
• GPL is also aiming to export to other countries of South East Asia, Middle East, Africa.
GDP Growth of the company:
• According to Director General of Drug Administration (DGDA), The pharmaceutical industry is
• growing at a CAGR of 15.6 per cent, greater than the growth rate of the nation's GDP which is
• about seven per cent. The industry is set to achieve avalue of $5.11 billion in 2023 from the
• current $2 billion
• SWOT Analysis: SOWT means strength , weakness, opportunity, threat.